The clinical research landscape for in-vitro diagnostics (IVD) and medical devices is experiencing a rapid evolution driven by technological advancements. The COVID-19 pandemic certainly spurred the development and integration of new technology platforms with necessity largely driving industry adoption. However, in the wake of the pandemic, many sponsors are not realizing the full potential of the latest advances to improve the management and execution of their clinical research programs.
Senior Vice President, Chief Technology Officer
As a forward-thinking Contract Research Organization (CRO), Beaufort has maintained momentum and continues to apply best-of-breed technology solutions that deliver measurable benefits for sponsors, sites, and patients. This technology focus has allowed our clients the ability to leverage our expertise and apply these innovations to streamline processes, enhance data quality, ensure regulatory compliance, and, ultimately, simplify and accelerate the development of ground-breaking products.
Optimizing the IVD and Medical Device Trial Journey with Technology
There are a wide variety of systems and tools that can help optimize operations within the clinical research paradigm and offer time and cost savings for sponsors.
eSource and Direct Data Capture:
Data acquisition within the trial environment remains a significant challenge. Studies are capturing more and more data all while maintaining the mandate for safety, quality, and completeness. For diagnostic trials, eSource allows for the direct capture of data from laboratory instruments and laboratory information management systems (LIMS), eliminating manual transcription errors and ensuring data integrity. Similarly, for medical device trials, eSource can integrate with device data streams, providing real-time insights into device performance. Direct Data Capture (DDC) allows clinical sites to input information directly in the Electronic Data Capture (EDC) system, removing cumbersome and time-intensive transcription from paper.eConsent and Patient Engagement:
Providing the ability to engage patients wherever they might be, eConsent platforms deliver a user-friendly interface for patients to electronically review informed consent documents, ask questions, and provide electronic signatures, enhancing patient engagement and streamlining the consent process. In addition, eConsent platforms can integrate directly with the EDC, allowing for efficiencies like automatic subject creation and the triggering of consent-driven workflows. Integration of hybrid solutions that continue to offer paper-based options helps eliminate adoption concerns for subject populations that are hesitant to use electronic forms.Data Integration and Real-Time Visibility:
Fragmentation of data across disparate systems can hinder efficient trial management. Advanced data integration tools allow for seamless exchange of information between clinical trial management systems (CTMS), LIMS, EDC and device data streams, providing a holistic view of the trial in real-time. Beaufort has found that having integrated platforms allows for the rapid performance of interim data analysis and enhanced visibility into overall trial trends and potential issues.Operational Analytics and Data-Driven Decisions:
Operational performance is crucial to running a successful trial. By bringing together data from various clinical platforms, the savvy CRO is able to provide key performance indicators around monitoring and site performance. These insights enable proactive course correction, improved resource allocation, and optimized trial execution.Cybersecurity and Data Protection:
The backdrop of ever-evolving cybersecurity threats presents sponsors with considerable challenges in ensuring their products are both compliant and secure. Add to this increasing regulatory requirements and it becomes critical to select a partner with extensive cybersecurity experience. Maintaining compliance with industry regulations like 21 CFR Part 11, HIPAA and GDPR is paramount. In addition, recent regulatory guidance has greatly expanded the need to document all components of a proposed product to include vulnerability assessment and threat modeling.Automation and Streamlined Workflows:
Repetitive tasks such managing regulatory documents, scheduling site visits and monitoring trial timelines can be automated, freeing up valuable human resources for higher-level activities like data analysis, risk management, recruitment/enrollment, and protocol development.
The Power of Partnership: Why Technical Experience Matters
Applying a holistic and platform-agnostic view ensures access to the best-fit solutions for each specific IVD or medical device trial
A CRO’s established relationships with a wide variety of platform providers offer a significant advantage for sponsor programs. Applying a holistic and platform-agnostic view ensures access to the best-fit solutions for each specific IVD or medical device trial, considering factors such as device compatibility, regulatory compliance, and integration capabilities.
Beaufort’s team has considerable experience in evaluating and utilizing the latest technology solutions. We bring a deep understanding of the strengths and value of leading platforms and can provide seamless integration and ongoing support, maximizing efficiencies and minimizing disruption for study teams.
Navigating the Evolving Regulatory Landscape and Addressing Emerging Challenges
The regulatory landscape for IVD and medical devices has also been evolving to address guidance issues as it relates to cybersecurity and technology. It is critical for a CRO to proactively monitor regulatory changes and ensure their technology stack remains compliant with the latest guidelines, such as the EU IVDR and the US FDA’s regulations for medical devices. Additionally, rapidly advancing fields like Artificial Intelligence (AI) hold exciting potential in areas like image analysis and clinical trial design, but also raise questions about validation, ethical considerations, and regulatory clarity. A proactive CRO, like Beaufort, actively engages with regulatory bodies and industry stakeholders to address these challenges and ensure trials remain compliant and ethically sound.
Choosing the Right Partner for Success
Selecting the right CRO is crucial for the success of IVD and medical device trials. Look for a partner with:
Proven track record of leveraging technology:
Experience in applying the latest technological advancements specifically within the context of IVD and medical device trials.Established relationships with leading platform providers:
Access to a wide range of best-fit technology solutions tailored to the specific needs of your trial.Commitment to navigating the evolving regulatory landscape:
Proactive approach to ensuring compliance with the latest IVD and medical device regulations.Deep understanding of IVD and medical device workflows:
Expertise in streamlining trial processes and optimizing data collection specific to these fields.Thorough knowledge of evolving Cybersecurity and Privacy requirements:
Wide experience with documenting and performing cybersecurity risk assessments, threat modeling, vulnerability remediation, and change management.
By partnering with a tech-savvy CRO like Beaufort that demonstrates these qualities, you gain a valuable extension of your team, equipped to drive efficiency, data quality, and ultimately, accelerate the development of innovative IVD and medical device solutions that improve patient care.
Contact us today to see how Beaufort applies technology to support your next clinical research project.
Learn More